PPD Laboratory Services, Therapeutic Focus
Advancing drug development across therapeutic areas
Developing a drug involves numerous challenges, including lengthy and complex trials, high costs, uncertainties, and the need for therapeutic expertise to address indication driven complexities and requirements. Navigating the evolving regulatory environment across a multitude of therapeutic indications and securing high-quality data are critical for the success of clinical trials.
Companies of all sizes turn to PPD™ Laboratory services to leverage our depth of knowledge in many therapeutic areas and the scientific acumen needed to advance successful drug programs.
Our global network of laboratories combines a dynamic, innovative approach with award-winning technologies to accelerate clinical trial performance and achieve regulatory success.
We have experience supporting clinical trials in more than 20 different therapeutic areas including metabolic, cardiology, neurology, oncology and endocrinology.
Metabolic testing for research and drug development
Drug development for metabolic disorders presents unique challenges because of complex disease mechanisms. Consequently, clinical trials necessitate tailored solutions, expert scientific support, flexibility in method validation, and multi-system approaches.
We go beyond standard metabolic testing by providing the scientific insights, biomarker innovation and comprehensive lab support drug developers need for success. Our robust operational framework and extensive expertise in emerging metabolic endpoints enable us to support programs focused on GLP-1 safety, mechanism-based biomarkers, and long-term cardiometabolic outcomes.
Companies partner with us to advance their therapies for diabetes, obesity, and related metabolic conditions, relying on our scientifically credible, integrated analytical testing solutions.
With more than three decades of bioanalytical experience our lab offers:
Biomarker-aligned development
Deep scientific expertise in complex biomarkers with custom assay development.
- Broad biomarker menu across adipokines, myokines, bone turnovers and immunologic biomarkers
- Custom and fit-for-purpose assay development
- Expertise in endocrine-immune-muscle interplay
Translational and regulatory alignment
Experience supporting IND-enabling studies and class-based safety packages, with biomarker strategies that evolve from early-phase to late-phase trials.
Drive your metabolic development program forward
Complete the form below to request a proposal or contact your local business development representative.